Interestingly, serum small EVs’ P-glycoprotein high levels are associated with resistance to docetaxel but not to cabazitaxel (78), thus representing a potential biomarker to guide the decision-making process in PCa patients. This evidence concerns the gene ABCB1 and posterior cortical atrophy.